Consumer Healthcare Products (CHP) Australia, following today’s Annual General Meeting, is pleased to announce our newly confirmed Board of Directors.

New Board Directors confirmed at the AGM:

• Dr Aniss Chami - CEO, Vitex Pharmaceuticals
• Andrew Jenkin - Managing Director, iNova Pharmaceuticals
• Alan Oppenheim - Managing Director, Ego Pharmaceuticals  
• Nadia Yu - Managing Director, Johnson & Johnson Consumer Health ANZ

New Board Directors appointed to fill skills-based vacancies following the AGM:

• Jonathan Biddle - General Manager, Care Pharmaceuticals
• Jonas Marques - SVP & Cluster Head, Bayer Australia and New Zealand
• David Rankine - Regional Director, Reckitt - ANZ Health

CHP Australia Board Chair, Phil Lynch, congratulated the Directors on their election, and welcomed the new Board.

“I look forward to working with the new Board; a very capable group of individuals who bring with them a diverse range of experiences and perspectives that will strengthen our organisation as we look towards a post-pandemic world.”

"COVID-19 has magnified the critical importance of good self-care for Australians’ health and wellbeing. Building on the growing momentum for greater self-care, CHP Australia will continue to collaborate with our self-care and health literacy partners to support a healthier Australia and a more sustainable healthcare system. "

The recently elected and appointed Directors will join the existing Board of Directors:

• Alison Holland - Head of Consumer – OTC, Aspen Pharmacare Australia
• Phil Lynch - Independent Director (Chair)
• Anish Patel - Area General Manager – ANZ, GSK Consumer Healthcare